Definitive Contract 75N92020C00006
Award Date
7/30/20
Potential Completion Date
10/31/22
Potential Value
$46M
Federal Agency
National Heart Lung and Blood Institute
Awardee
Helix Opco LLC
Ultimate Awardee
Not listed
NAICS Category
621511 - Medical Laboratories
PSC Category
Q301 - Reference Laboratory Testing
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Not Competed
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
San Mateo, CA 94401, USA
Solicitation Procedures
Only One Source
Number Of Offers Received
1
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
Sonic Healthcare USA Inc. was awarded a firm fixed price definitive contract valued at $20,550,149.95 by the National Institutes of Health National Heart Lung and Blood Institute to rapidly expand existing framework for deploying large-scale COVID-19 RT-PCR testing platforms and distributing testing capacities under the Rapid Acceleration of Diagnostics program. The work will be performed in Austin, Texas over a one year period ending in August 2021. This contract was awarded...
The National Institutes of Health National Heart Lung and Blood Institute awarded a $15 million firm fixed price purchase order to National Collegiate Inventors & Innovators Alliance, Inc., doing business as Venturewell, for the Rapid Acceleration of Diagnostics (RADX) Initiative - Phase 0. As part of the RADX Initiative to accelerate the development, testing, and implementation of novel diagnostics for COVID-19, this contract will support Venturewell's efforts to advance diagnostics...
The Department of Health and Human Services National Institutes of Health National Heart Lung and Blood Institute awarded a firm fixed price purchase order contract to Ascella Biosystems Inc., a for-profit manufacturer, on January 13, 2021. The $250,000.00 contract is for RADX-TECH - SUPPORT SERVICES NEEDED FOR WORK PACKAGE 1 and is associated with the Coronavirus COVID-19 national interest action. The contract does not have a set-aside designation and is scheduled for completion on January...
This is a definitive contract awarded by the National Heart, Lung, and Blood Institute (NHLBI), a civilian agency within the National Institutes of Health (NIH), to the National Collegiate Inventors & Innovators Alliance, Inc. (doing business as Venturewell), a non-profit organization. The $33,379,628.30 firm fixed-price contract is for NHLBI's Rapid Acceleration of Diagnostics (RADx) initiative, providing ITAP consultants and infrastructure support. The contract has a period of...
This is a $5,000,000.00 firm fixed price contract awarded by the Centers for Disease Control and Prevention (CDC) to Helix Opco LLC, a for-profit limited liability company based in San Mateo, California. The contract was awarded on September 30, 2022 under the CDC's "FY22 BAA - APPLIED RESEARCH TO ADDRESS EMERGING PUBLIC HEALTH PRIORITIES" solicitation, with a period of performance ending on September 29, 2023. The contract does not have a set-aside designation. Helix Opco has...
<p>The National Heart, Lung and Blood Institute, a component of the National Institutes of Health within the Department of Health and Human Services, awarded a definitive contract valued at $1,099,350.00 to Rosalind, Inc. for Rapid Acceleration of Diagnostics technology. Rosalind, Inc. will perform all work at its division location in Bethesda, Maryland under firm fixed pricing from December 5, 2022 through December 4, 2023. No subcontractors were identified.</p>
This federal contract award, valued at $10,691,445.48, was issued by the National Heart Lung and Blood Institute, a civilian agency within the U.S. government, to the National Collegiate Inventors & Innovators Alliance, Inc. (doing business as Venturewell), a non-profit organization. The contract is for Rapid Acceleration of Diagnostics (RADx) Clinical Evaluation Services (CES) - Task Order 9. Venturewell has extensive experience managing federal contracts and grants focused on advancing...
This is a federal Delivery Order contract awarded by the National Heart Lung and Blood Institute (NHLBI), part of the National Institutes of Health (NIH) within the Department of Health and Human Services. The contract, valued at $131,241.00, is for Rapid Acceleration of Diagnostics (RADx) Clinical Evaluation Services. The prime contractor is the National Collegiate Inventors & Innovators Alliance, Inc. (doing business as Venturewell), a non-profit organization based in Hadley,...
The Department of Health and Human Services National Institutes of Health National Institute of Biomedical Imaging and Bioengineering awarded a $20.7 million firm fixed price definitive contract to Associated Pathologists, LLC (doing business as Pathgroup) for the Rapid Acceleration of Diagnostics (RADX) ATP Program - Project #7338. The contract is being funded under the Coronavirus COVID-19 national interest action code and will support RADX's goal of accelerating the development,...
This is a firm fixed-price federal contract awarded by the National Heart Lung and Blood Institute (NHLBI), part of the National Institutes of Health (NIH), to Illumina, Inc. The contract, valued at $87,365.00, is for the rapid establishment of a massively scaled next-generation sequencing (NGS) laboratory to support COVID-19 testing in the United States. This contract was awarded under the RAPID ACCELERATION OF DIAGNOSTICS (RADX) program, which aims to speed the development, validation, and...